Viability of developmental stages of Schistosoma mansoni quantified with xCELLigence worm real-time motility assay (xWORM)
Rinaldi, Gabriel, Loukas, Alex, Brindley, Paul J., Irelan, Jeff T., and Smout, Michael J. (2015) Viability of developmental stages of Schistosoma mansoni quantified with xCELLigence worm real-time motility assay (xWORM). International Journal for Parasitology: Drugs and Drugs Resistance, 5 (3). pp. 141-148.
|
PDF (Published Version)
- Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (1MB) | Preview |
Abstract
Infection with helminth parasites causes morbidity and mortality in billions of people and livestock worldwide. Where anthelmintic drugs are available, drug resistance is a major problem in livestock parasites, and a looming threat to public health. Monitoring the efficacy of these medicines and screening for new drugs has been hindered by the lack of objective, high-throughput approaches. Several cell monitoring technologies have been adapted for parasitic worms, including video-, fluorescence-, metabolism enzyme- and impedance-based tools that minimize the screening bottleneck. Using the xCELLigence impedance-based system we previously developed a motility-viability assay that is applicable for a range of helminth parasites. Here we have improved substantially the assay by using diverse frequency settings, and have named it the xCELLigence worm real-time motility assay (xWORM). By utilizing strictly standardized mean difference analysis we compared the xWORM output measured with 10, 25 and 50 kHz frequencies to quantify the motility of schistosome adults (human blood flukes) and hatching of schistosome eggs. Furthermore, we have described a novel application of xWORM to monitor movement of schistosome cercariae, the developmental stage that is infectious to humans. For all three stages, 25 kHz was either optimal or near-optimal for monitoring and quantifying schistosome motility. These improvements in methodology sensitivity should enhance the capacity to screen small compound libraries for new drugs both for schistosomes and other helminth pathogens at large.
| Item ID: | 40056 |
|---|---|
| Item Type: | Article (Research - C1) |
| ISSN: | 2211-3207 |
| Keywords: | Helminths; viability; xCELLigence; Schistosome; strictly standardized mean difference (SSMD); high-throughput |
| Additional Information: | © 2015 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an open access article under the CC BY-NC-ND license. |
| Funders: | National Institute of Allergy and Infectious Disease (NIAID), National Health and Medical Research Council of Australia (NHMRC) |
| Projects and Grants: | NIAID award R21 AI109532, NIAID award R01AI072773, NHMRC grant APP1037304, NHMRC Principal Research Fellowship APP1020114 |
| Date Deposited: | 12 Aug 2015 23:46 |
| FoR Codes: | 11 MEDICAL AND HEALTH SCIENCES > 1108 Medical Microbiology > 110803 Medical Parasitology @ 30% 07 AGRICULTURAL AND VETERINARY SCIENCES > 0707 Veterinary Sciences > 070708 Veterinary Parasitology @ 20% 10 TECHNOLOGY > 1004 Medical Biotechnology > 100402 Medical Biotechnology Diagnostics (incl Biosensors) @ 50% |
| SEO Codes: | 92 HEALTH > 9201 Clinical Health (Organs, Diseases and Abnormal Conditions) > 920109 Infectious Diseases @ 40% 83 ANIMAL PRODUCTION AND ANIMAL PRIMARY PRODUCTS > 8303 Livestock Raising > 830399 Livestock Raising not elsewhere classified @ 20% 92 HEALTH > 9202 Health and Support Services > 920203 Diagnostic Methods @ 40% |
| Downloads: |
Total: 1099 Last 12 Months: 7 |
| More Statistics |
Actions (Repository Staff Only)
 |
Item Control Page |